High-throughput screening for new drugs based on stem cell technologies is developing in a few centers around the world. The technology potentially will dramatically accelerate the search of new small molecules – regulators of cell fate, differentiation, proliferation and motility. Also such screening can replace a lot of manual work, conventional lab. animal-based assays and make it more time- and cost effective.
To get closer to opportunities of stem cell based high-throughput screening technology, I’d like to share with you a lecture, given by Mickie Bhatia during the “Future of Medicine Conference 2009“, held in MaRS Toronto’s complex in November 2009.
I’d like to highlight that he proposed to replace xenotransplantation assays for screening drugs targets of cancer stem cells (2 years in time) for robotic high-throughput screening (3 weeks) – watch min:sec 20:30 of his talk.
Also watch Mickie’s Bhatia interview:
Related posts:
